Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a n ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...

Kelly Bodu was 28 weeks pregnant with her second child when she found a lump in her breast - and after a few tests at the doctor’s office – she was diagnosed with stage three breast cancer.